第二屆廣州核酸國際論壇 議程盛大公布
主題：Nucleic Acids Translational Research & Therapeutics (siRNA, miRNA, lncRNA, antisense, CRISPR)
第二屆廣州核酸國際論壇（CNAF）以核酸轉(zhuǎn)化研究與治療為主題，旨在推動核酸研究和治療藥物的發(fā)展，加強中國與國際的交流合作，促進中國核酸生物產(chǎn)業(yè)的進步，展望核酸技術(shù)作為創(chuàng)新藥物第三大發(fā)展引擎的美好前景。
本屆論壇特邀20多位國際頂級科學(xué)家和企業(yè)家參會演講，嘉賓囊括諾貝爾獎得主、世界百強藥企的高級主管、世界頂級學(xué)府的著名教授、核酸制藥上市公司的總裁、核酸治療世界聯(lián)盟主席等，內(nèi)容涵蓋RNAi、microRNA、lncRNA、antisense、mRNA、exon-skipping、CRISPR等核酸技術(shù)最新進展，包括從核酸基礎(chǔ)研究到產(chǎn)業(yè)化，從臨床前開發(fā)到臨床研究，并分享去年世界首個核酸藥物成功上市的經(jīng)驗。論壇的召開，將為國內(nèi)科學(xué)家及研究生提供與本領(lǐng)域?qū)W術(shù)權(quán)威面對面交流的難得機會，為國內(nèi)從事生物制藥的企業(yè)單位提供與世界知名藥企建立合作的紐帶。
我們期待與您相聚美麗羊城，共同迎接核酸治療時代的來臨！
主辦單位：專家聯(lián)誼會生物醫(yī)藥和生命科學(xué)專業(yè)委員會
中國生化與分子生物學(xué)會核糖核酸專業(yè)委員會
中國科學(xué)院廣州生物醫(yī)藥與健康研究院
中山大學(xué)
承辦單位：廣州市銳博生物科技有限公司
開幕主旨演講
Craig Mello教授
美國麻省大學(xué)醫(yī)學(xué)院教授
2006年諾貝爾生理學(xué)或醫(yī)學(xué)獎獲得者
主旨演講
 |
 |
 |
 |
|
Troels Koch博士
丹麥Santaris / Roche制藥公司首席技術(shù)官，研發(fā)副總裁
|
Ekkehard Leberer教授
法國賽諾菲研發(fā)聯(lián)盟管理高級總監(jiān), IMI COMPACT Consortium常務(wù)董事
|
Muthiah Manoharan博士
美國Alnylam制藥公司高級副總裁，新藥開發(fā)負(fù)責(zé)人
|
Brett Monia博士
美國Isis 制藥公司高級副總裁
Oligonucleotide Therapeutics Society當(dāng)選主席
|
大會擬定議程
|
Wed, Nov 5, 2014
|
||
|
Registration 13:00-18:00
|
||
|
|
||
|
Thu, Nov 06, 2014 (Day 1)
|
||
|
|
Chair
|
Mano Manoharan, PhD Senior Vice President, Alnylam Pharmaceuticals, USA
|
|
08:30-08:45
|
Introduction
|
CNAF Organizing Committee
|
|
08:45-09:30
|
Opening Keynote
|
Craig Mello, PhD Professor, University of Massachusetts Medical School, HHMI, 2006 Nobel Prize Winner, USA
Title: RNA-guided genome defense and new frontiers in biotech and medicine
|
|
09:30-10:10
|
Keynote
|
Brett Monia, PhD Senior Vice President, Isis Pharmaceuticals, OTS President, USA
Title: Transforming drug discovery for human therapeutics with antisense technology
|
|
10:10-10:35
|
Plenary
|
Judy Lieberman, MD, PhD Professor, Program Chair, Harvard Medical School, USA
Title: Targeted gene knockdown to treat cancer
|
|
10:35-10:55
|
Tea Break
|
|
|
10:55-11:20
|
Plenary
|
Matthew Porteus, MD, PhD Professor, Stanford School of Medicine, CRISPR Therapeutics Founder, USA
Title: Genome editing using engineered nucleases
|
|
11:20-11:45
|
Plenary
|
Erwei Song, MD, PhD Professor and Vice Dean, Sun Yat-Sen Memorial Hospital, China
Title: BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10
|
|
11:45-12:00
|
Technology
|
Rick Hogrefe, PhD Founder, President and Chief Executive Officer, TriLink BioTechnologies
Title: Designing a mRNA therapeutic suitable for scale up
|
|
12:00-13:30
|
Lunch
|
|
|
13:30-13:35
|
Chair
|
Brett Monia, PhD Senior Vice President, Isis Pharmaceuticals, OTS President, USA
|
|
13:35-14:15
|
Keynote
|
Troels Koch, PhD Senior Vice President and Chief Technology Officer, Santaris / Roche, Denmark
Title: LNA antisense – concepts & status
|
|
14:15-14:40
|
Plenary
|
Dmitry Samarsky, PhD Executive Vice President, Technology Development, RiboBio, China
Title: In vivo delivery of therapeutic oligonucleotides and potential applications for cancer
|
|
14:40-15:05
|
Plenary
|
Georg Sczakiel, PhD Professor, University of Lübeck, Germany
Title: Target RNA is involved in guide strand loading of Argonaute-2 and siRNA-induced RNA interference
|
|
15:05-15:25
|
Tea Break
|
|
|
15:25-15:50
|
Plenary
|
Peixuan Guo, PhD Professor, William S. Farish Fund Endowed Chair, University of Kentucky, USA
Title: A new generation of drugs from the emerging field of RNA nanotechnology
|
|
15:50-16:15
|
Plenary
|
Yi Jin, PhD Executive Vice President, Suzhou Ribo Life Science, China
Title: RNAi based therapeutics for Hepatitis B
|
|
16:15-16:30
|
Technology
|
Suresh Srivastava, PhD Founder and President, ChemGenes, USA
Title: BMEG oligonucleotides for efficient cellular delivery for therapeutic and molecular biological applications
|
|
16:30-16:55
|
Plenary
|
David Lewis, PhD Chief Scientific Officer, Arrowhead Research Corporation, USA
Title: Using Dynamic Polyconjugate® (DPC) technology to advance RNAi-based therapeutics
|
|
16:55-17:00
|
Day End
|
CNAF Organizing Committee
|
|
Fri, Nov 07, 2014 (Day 2)
|
||
|
09:00-09:05
|
Chair
|
Troels Koch, PhD Senior Vice President and Chief Technology Officer, Santaris / Roche, Denmark
|
|
09:05-09:45
|
Keynote
|
Ekkehard Leberer, PhD Professor, Senior Director of R&D Alliance Management, Sanofi, Germany
Title: Nucleic acid therapeutics: opportunities and challenges for innovation in drug development
|
|
09:45-10:10
|
Plenary
|
William Marshall, PhD President and Chief Executive Officer, Board Director, miRagen Therapeutics, USA
Title: Discovery and development of microRNA targeting therapeutics
|
|
10:10-10:35
|
Plenary
|
Micky Tortorella, PhD Chief Technology Officer and Vice President for Drug Discovery and Technology Transfer, Guangzhou Institutes of Biomedicine and Health, China
Title: Intra-articular delivery of siRNA-conjugates as new disease modifying osteoarthritis drugs
|
|
10:35-10:55
|
Tea Break
|
|
|
10:55-11:20
|
Plenary
|
Chengyu Jiang, PhD Professor, Chair, Peking Union Medical College, CAMS, China
Title: Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro
|
|
11:20-11:45
|
Plenary
|
Marc Lemaitre, PhD Chief Executive Officer, Sirnaomics, USA / China
Title: Improving siRNA therapeutics using polymer-nanoparticle (PNP) delivery: recent pre-clinical results with STP705 against skin scars
|
|
11:45-12:00
|
Technology
|
Kimo Sanderson Vice President, Asahi Kasei, Japan
Title: Therapeutic oligonucleotides from discovery to development: the importance of proper production and scale up
|
|
12:00-13:30
|
Lunch
|
|
|
13:30-13:35
|
Chair
|
William Marshall, PhD President, Chief Executive Officer, Board Director, miRagen Therapeutics, USA
|
|
13:35-14:15
|
Keynote
|
Mano Manoharan, PhD Senior Vice President, Alnylam Pharmaceuticals, USA
Title: Chemical strategies for systemic delivery of RNAi drugs
|
|
14:15-14:40
|
Plenary
|
Dirk Haussecker, PhD Founder and Curator, RNAi Therapeutics Blog, Germany
Title: RNA therapeutics emerging as major drug discovery engine
|
|
14:40-15:05
|
Plenary
|
TBD
|
|
15:05-15:20
|
Technology
|
Carina Andersson, PhD Marketing Head, GE, USA
Title: A manufacturing solution of oligonucleotides
|
|
15:20-15:40
|
Tea Break
|
|
|
15:40-16:05
|
Plenary
|
Sven Klussmann, PhD Chief Scientific Officer, NOXXON Pharma, Germany
Title: From bench to bedside – the conversion of mirror-image oligonucleotides into therapeutics
|
|
16:05-16:30
|
Plenary
|
Ryszard Kole, PhD Distinguished Scientist, Professor, Sarepta Therapeutics, USA
Title: Eteplirsen, a phosphorodiamidate morpholino oligonucleotide, as treatment for Duchenne muscular dystrophy (DMD)
|
|
16:30-16:55
|
Plenary
|
René Thürmer, PhD Deputy Head of the Unit Pharmaceutical Biotechnology, BfArM - Federal Institute for Drugs and Medical Devices, Germany
Title: Regulatory aspects of nucleic acids therapeutics
|
|
16:55-17:15
|
Closing Remarks
|
Craig Mello, PhD Professor, University of Massachusetts Medical School, HHMI, 2006 Nobel Prize Winner, USA
|
會議時間：2014年11月5-7日
會議地點：廣州科學(xué)城翡翠皇冠假日酒店
會議語言：英語
論壇網(wǎng)站：www.cnaf.org.cn（點此注冊）
贊助企業(yè)：
白金贊助
金牌贊助
銀牌贊助
|
|
|
|
|
銅牌贊助
專項贊助
聯(lián)系我們：
|
贊助咨詢： |
注冊及其他咨詢： |
- 2025第25屆合肥食品安全檢測技術(shù)高峰論壇通知
- 進科馳安攜流式分選儀等參加全國細(xì)胞外囊泡大會
- 第7屆北京國際醫(yī)療器械及醫(yī)院建設(shè)展火熱招商中
- CPHI&PMEC 2025世界制藥原料中國展預(yù)登記已開啟
- 第十七屆ChinaBio®生物醫(yī)藥產(chǎn)業(yè)國際合作大會通知
- 2025北京檢驗醫(yī)療與體外診斷及耗材展火熱招商中
- 霍爾斯參加2024未來微藻生物制造創(chuàng)新研討會
- 2024年I2SL國際可持續(xù)發(fā)展實驗室會議成功舉辦
- 澤權(quán)儀器精彩亮相2024科學(xué)家創(chuàng)新大會
- 第十三屆生物質(zhì)能源與有機固廢資源化利用論壇通知
- 第四屆三亞國際種業(yè)科學(xué)家大會日程表&嘉賓名單
- 2025合成生物概念驗證平臺技術(shù)與智能裝備論壇通知
- FFC 2025功能性食品大會通知
- 博普特種質(zhì)資源產(chǎn)品將參展第四屆三亞種業(yè)科學(xué)家大會
- 2025 細(xì)胞產(chǎn)業(yè)大會（上海）通知
- 生物醫(yī)藥檢測與試劑供應(yīng)商翼和生物向全國招募經(jīng)銷商
- 線上課程：豬腸道冠狀病毒與人體無聲的代謝斗爭
- 一作直播：抗性淀粉通過重塑腸道微生物群緩解肥胖
- SBC&�；�2024年第一期類器官初級培訓(xùn)班邀請函
- SBC邀您參加2024空間多維組學(xué)創(chuàng)新轉(zhuǎn)化研討會
- 孚森推出多色全景成像數(shù)據(jù)分析服務(wù)
- 2024全新繪譜學(xué)堂公開課：心血管疾病研究專題講座
- SBC完成首批CosMx™ SMI空間原位分子成像分析實驗
- Simoa® Advantage PLUS試劑煥新升級，更穩(wěn)定準(zhǔn)確
- CosMx Human 6K單細(xì)胞空間原位數(shù)據(jù)集預(yù)售即將開啟
- SBC論壇邀請：多組學(xué)與系統(tǒng)生物學(xué)前沿技術(shù)
- 繪譜學(xué)堂：非人靈長類動物NASH模型構(gòu)建與應(yīng)用研究
- SBC講座：微量蛋白檢測在外泌體研究中的前沿應(yīng)用
- SBC線上講座：國家自然科學(xué)基金申報技巧經(jīng)驗分享
- MCE 定制化多樣性SPR 檢測技術(shù)服務(wù)強勢上線
Copyright(C) 1998-2024 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com